Match!
Michael M. Kreusser
Heidelberg University
38Publications
15H-index
906Citations
Publications 38
Newest
#1Sonja Hamed (Heidelberg University)H-Index: 3
#2Schmack Bastian (Heidelberg University)H-Index: 16
Last.Michael M. Kreusser (Heidelberg University)H-Index: 15
view all 9 authors...
Background Ventricular assist devices (VAD) are increasingly used as long-term treatment for advanced heart failure. However, survival after VAD implantation is still unsatisfactory, and no specific outpatient follow-up algorithms have been formally established. Here, we evaluate the effect of an intensified follow-up protocol (IFUP) on survival rates and VAD-associated complications.
2 CitationsSource
#1Michael M. Kreusser (Heidelberg University)H-Index: 15
#2Martin J. Volz (Heidelberg University)
Last.Philip Raake (Heidelberg University)H-Index: 23
view all 10 authors...
Background Cardiac amyloidosis, caused by deposition of immunoglobulin light chains (AL) or transthyretin (ATTR), carries a poor prognosis. Established risk scores for amyloidosis may not predict outcomes in those patients who develop advanced heart failure and who are potential candidates for heart transplantation. Here, we aimed to identify predictive parameters for patients with severe heart failure due to amyloidosis.
Source
#1Michael M. Kreusser (Heidelberg University)H-Index: 15
#2Sven T. Pleger (Heidelberg University)H-Index: 26
Last.Philip Raake (Heidelberg University)H-Index: 23
view all 7 authors...
Background The Cardioband system enables percutaneous surgical-like direct mitral valve annuloplasty and, thereby, repair of severe functional mitral valve regurgitation (MR) in patients with advanced systolic heart failure (HF) and dilation of the left ventricular (LV) annulus. Since the device is anchored by screws in the LV annulus, limited myocardial injury is likely to occur.
Source
#1Michael M. Kreusser (Heidelberg University)H-Index: 15
#2Nicolas Geis (Heidelberg University)H-Index: 9
Last.Philip Raake (Heidelberg University)H-Index: 23
view all 8 authors...
Background Percutaneous mitral valve repair (PMVR) via MitraClip implantation is a therapeutic option for high-risk or non-surgical candidates with severe mitral regurgitation (MR) and advanced stages of heart failure (HF). However, these patients have a high mortality despite PMVR, and predictors for outcomes are not well established. Here, we evaluated invasive hemodynamics, echocardiography parameters, and biomarkers to predict outcomes after PMVR in severe HF patients.
4 CitationsSource
#1Schmack BastianH-Index: 16
#2Mina FaragH-Index: 7
Last.Arjang RuhparwarH-Index: 21
view all 12 authors...
Background: Modern left ventricular assist devices (LVAD) have evolved to become standard of care in severe heart failure (HF) patients. Right HF (RHF) is a major complication responsible for early mortality. Several techniques for temporary right ventricular assist device (t-RVAD) have been described before, baring relevant disadvantages such as limited mobilization or the need for re-thoracotomy. We describe the results of an alternative technique for t-RVAD using the Tandem Heart™ with Protek...
1 CitationsSource
A 56-year-old male presented in critical state of heart failure treated by an extracorporeal life support system (ECLS). He was transferred to our hospital for evaluation of left ventricular assist device (LVAD) implantation. Echocardiographic findings showed a severely impaired left ventricular function with an ejection fraction (EF) of 15% and normal right ventricular function.
Source
#2Schmack BastianH-Index: 16
Last.Vedat SchwengerH-Index: 36
view all 12 authors...
1 CitationsSource
#1Bruna Gomes (Heidelberg University)H-Index: 2
#2Raffi Bekeredjian (Heidelberg University)H-Index: 37
Last.Michael M. Kreusser (Heidelberg University)H-Index: 15
view all 9 authors...
Source
#1Michael M. Kreusser (Heidelberg University)H-Index: 15
#2Philip Raake (Heidelberg University)H-Index: 23
Patients with acute dyspnea resulting from acute heart failure should be rapidly assessed and stabilized. First, patients should be put in a seated posture and, if necessary, supplemental oxygen and ventilatory support (noninvasive or invasive, see below) should be provided [1]. After that, therapeutic aims should be focused on the correction of hemodynamic and intravascular volume abnormalities. Therapy has to be tailored to the individual situation, however, diuretics are the mainstay of thera...
Source
#1Nicolas Geis (Heidelberg University)H-Index: 9
#2Sven T. Pleger (Heidelberg University)H-Index: 26
Last.Philip Raake (Heidelberg University)H-Index: 23
view all 9 authors...
2 CitationsSource
1234